Inhaled Nitric Oxide Market Will Reach 1490 Million US$ by 2025

This report studies the global Inhaled Nitric Oxide market status and forecast, categorizes the global Inhaled Nitric Oxide market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.Nitric oxide is a chemical compound in gas form that is sometimes used to treat infants with severe breathing problems associated with narrow blood vessels in the lungs. It works by relaxing smooth muscle to widen (dilate) blood vessels, especially in the lungs. Nitric oxide is usually used together with a breathing machine (ventilator).

Inhaled nitric oxide (iNO) is recognized as a potent and selective pulmonary vasodilator that does not decrease systemic vascular tone. The therapeutic application of iNO in human was first described in 1990s. INO therapy was effective to improve oxygenation in infants with persistent pulmonary hypertension of the newborn (PPHN). Owing to its selective pulmonary vasodilator effects, iNO therapy is an important treatment for term newborns with hypoxemic respiratory failure due to PPHN. The Food and Drug Administration of the United States of America first approved iNO in 1999 for use as a medical gas to treat hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension in term and late preterm neonates. Thereafter, iNO therapy is clinically applied to treat PPHN in term and late preterm neonates without consensus.

The market is highly concentrated, with high technical and professional level. Key vendors in this market are Mallinckrodt, Praxair and Air Liquide, they are taking up to 91.19% market share in 2017. Inhaled Nitric Oxide types commonly used in this market are 800 ppm and 100 ppm, small players tend to produce lower purity products, such as 1000 ppm or so.

According to the research, North America and Europe comprised the biggest consumption areas. Other markets like Japan and China are growing relatively slow.Though the gross margin is high, but with complex production process and acquisition between enterprises, we tend to believe that this market is going to keep the monopoly status in the forecast period.

The global Inhaled Nitric Oxide market is valued at 780 million US$ in 2017 and will reach 1490 million US$ by the end of 2025, growing at a CAGR of 8.4% during 2018-2025.

The major manufacturers covered in this report

Mallinckrodt

Praxair

Air Liquide

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

99.92% Purity

99.99% Purity

Other

Request Sample Copy of Report@ https://www.qyresearch.com/sample-form/form/240808/global-inhaled-nitric-oxide-market

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including

ARDS

PPHN

Other Diseases

Market size split by Region

•North America
•Asia-Pacific
•Europe
•Central & South America
•Middle East & Africa

Benefits of Purchasing QY Research Report

• Analyst Support: Get you query resolved from our expert analysts before and after purchasing the report
•Customer's Satisfaction: Our expert team will assist with all your research needs and customize the report
• Inimitable Expertise: Analysts will provide deep insights about the reports
• Assured Quality: We focus on the quality and accuracy of the report

Request to Buy Full Report@ https://www.qyresearch.com/settlement/pre/ebd66890de1b17ef2c08510ba0896a94,0,1

QYResearch established in 2007, focus on custom research, management consulting, IPO consulting, industry chain research, data base and seminar services. The company owned a large basic data base (such as National Bureau of statistics database, Customs import and export database, Industry Association Database etc), expert's resources (included energy automotive chemical medical ICT consumer goods etc.

QY Research, INC.
17890 Castleton,
Suite 218,
City of industry, CA – 91748
USA: +1 626 295 2442
Email: enquiry@qyresearch.com
Web: http://www.qyresearch.com

This release was published on openPR.